Protara Therapeutics, Inc. Quarterly Return On Equity in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protara Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2015 to Q2 2024.
  • Protara Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -55 %, a 13.5% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Equity for 2023 was -49.7 %, a 1.55% decline from 2022.
  • Protara Therapeutics, Inc. annual Return On Equity for 2022 was -49 %, a 81% decline from 2021.
  • Protara Therapeutics, Inc. annual Return On Equity for 2021 was -27.1 %, a 3.09% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -55 +8.58 +13.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -58.8 -5.43 -10.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -49.7 -0.76 -1.55% Oct 1, 2023 Dec 31, 2023
Q3 2023 -77.1 -52.2 -210% Jul 1, 2023 Sep 30, 2023
Q2 2023 -63.6 -38 -149% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.4 -26.5 -98.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -49 -21.9 -81% Oct 1, 2022 Dec 31, 2022
Q3 2022 -24.9 +0.04 +0.16% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.6 -2.95 -13% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.9 -3.56 -15.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -27.1 -0.81 -3.09% Oct 1, 2021 Dec 31, 2021
Q3 2021 -24.9 +10.1 +28.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.6 +49.5 +68.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -23.3 +77.5 +76.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26.2 +873 +97.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -35 +372 +91.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -72.2 +73.4 +50.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -101 +9.58 +8.68% Jan 1, 2020 Mar 31, 2020
Q4 2019 -899 -801 -819% Oct 1, 2019 Dec 31, 2019
Q3 2019 -407 -334 -455% Jul 1, 2019 Sep 30, 2019
Q2 2019 -146 -56.4 -63.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -110 -21.7 -24.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -97.8 -10.2 -11.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -73.3 +16.1 +18% Jul 1, 2018 Sep 30, 2018
Q2 2018 -89.1 -17.1 -23.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -88.7 -20.5 -30% Jan 1, 2018 Mar 31, 2018
Q4 2017 -87.7 -28.1 -47.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -89.4 -37.8 -73.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -72 -28.6 -65.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -68.3 -32.9 -93% Jan 1, 2017 Mar 31, 2017
Q4 2016 -59.6 -29.5 -98.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -51.6 -41.3 -401% Jul 1, 2016 Sep 30, 2016
Q2 2016 -43.4 -17.7 -68.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -35.4 Jan 1, 2016 Mar 31, 2016
Q4 2015 -30.1 Oct 1, 2015 Dec 31, 2015
Q3 2015 -10.3 Jul 1, 2015 Sep 30, 2015
Q2 2015 -25.8 Apr 1, 2015 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.